Anne Lenaers is a pharmacist and regulatory expert at the Belgian Federal Agency for Medicines and Health Products (FAMHP/AFMPS). Working within the R&D Division of DG PRE, she acts as Belgium's National Contact Point for the Clinical Trials Regulation (CTR) and contributes to European regulatory collaboration as a member of the Clinical Trials Coordination Group (CTCG).

Denis Lacombe graduated with his MD from the University of Marseilles (France) in 1988 and obtained a Master Post-Doctoral Fellowship at The Roswell Park Cancer Institute (Buffalo, NY USA) for research in pharmacology and pharmacokinetics from 1989 to 1991. From 1991 to 1993, he worked as a Clinical Research Advisor in charge of the development of a new drug in oncology in the pharmaceutical industry.
Dr Lacombe joined the EORTC in 1993 as a research fellow and quickly became a very active and productive Clinical Research Physician involved in the conduct of clinical research from protocol development through publication for a number of oncology indications from phase I to phase III. Dr Lacombe contributed to the strategic evolution of the EORTC pan-European clinical and translational research infrastructure as well as developing partnerships with multiple stakeholders.
Dr Lacombe rose to the position of Director EORTC Headquarters in 2010, was appointed Director General in April 2015 and Chief Executive Officer in June 2021. In his current position, Denis Lacombe leads all activities promoting the EORTC as a major European organization in Cancer Clinical and Translational Research, including scientific activities, public relations and medium-term strategies as defined by the EORTC Board as well as internal and external communications.

Frank is a senior strategist at the intersection of global healthcare, life sciences supply chains, and academic research, 
with a career spanning more than three decades. His work focuses on strengthening critical pharmaceutical and MedTech 
supply chains, integrating digital and AI-driven health applications, and advancing education at the nexus of industry and 
academia.
He began his career in 1989 in critical patient care at one of Europe’s largest university hospitals, where he developed deep
expertise in organ, tissue, and cell transplantation, as well as intensive care medicine. This clinical foundation continues to 
inform his strategic perspective on healthcare systems and precision therapy logistics.
Over the past 15 years, Frank has emerged as a leading voice in life sciences supply chain strategy, with a particular 
emphasis on resilient, high-quality, and sustainable pharmaceutical logistics. His work increasingly addresses global 
vulnerabilities, geopolitical disruptions, and the transformation of supply networks that underpin access to essential and 
life-saving therapies.
A prolific academic contributor, Frank has authored more than 250 peer-reviewed scientific publications and over 30 
international industry white papers. He is a frequent keynote speaker and commentator, with more than 400 international 
lectures and regular contributions to global media on healthcare and supply chain resilience. His academic engagement is 
further reflected in his ongoing pursuit of advanced studies and research both in medical and supply chain research.
Frank holds several executive and academic appointments. He is actively involved in teaching and program development at 
the University of Antwerp and serves on the business faculty of Antwerp Management School and Thomas More University 
of Applied Sciences. He is a board member of the Advisory Board on Global Supply Chain at Antwerp Management School 
and contributes to the at.las ATMP Supply Chain Excellence Centre. He is also co-founder and program co-director of the 
International Pharma Logistics Masterclass, “Where Business Meets Academics” and the Pharma Logistics Winter 
University, both designed to bridge strategic industry insights with academic rigor.
Beyond his professional work, Frank draws inspiration from astronomy and astrophysics, pursuits he actively studies 
alongside outdoor activities such as mountain biking and culinary exploration. He is a strong advocate for interdisciplinary 
thinking, diversity of perspectives, and the role of implementation science and knowledge-sharing as catalysts for 
meaningful innovation and sustainable development.

CEO, Mediconed Consultancy
Secretary General Pharma.Aero
Member of the Advisory Board of Global Supply Chain AMS
Faculty Antwerp Management School and University of Antwerp
Faculty University of Applied Sciences Leuven and Thomas More Academy

Jade Verrept is Program Manager at the Provincial Development Authority Antwerp, as well as co-founder of the Antwerp ATMP ecosystem at.las. Jade is responsible for advancing the province’s regional innovation agenda, focusing on new technologies in life sciences and logistics. Her focus is both on the development of innovation campuses, and on the creation of dynamic innovation clusters.

Katrien Asnong graduated with a Master of Science in Nursing from the Catholic University of Leuven in 2000, after obtaining her bachelor's degree in nursing in 1997. She began her career as a research nurse in the IBD unit of Professor Rutgeerts at University Hospitals Leuven, where she gained extensive experience in the care of patients with inflammatory bowel disease (IBD) and in clinical research. After five years, she moved to the private sector, where she worked as a Clinical Research Associate (CRA) and later as a Clinical Project Leader in the medical device industry. However, missing direct patient contact and hands-on clinical work, she decided to return to IBD care. In 2014, she joined the IBD Clinic of Dr. Bossuyt at Imelda Hospital in Bonheiden. There, she coordinates clinical trials in Crohn's disease and ulcerative colitis as part of the clinical research nursing team. Katrien has been a member of BINAstoria, the Belgian professional association for healthcare professionals involved in the care of patients with inflammatory bowel disease (IBD), since June 2019. She served on its board from November 2019 to 2021. Since 2024, she has been teaching the course Introduction to Clinical Trials in the PXL Next postgraduate IMID programme. In 2026, she obtained her qualification as a Nurse Specialist. Katrien is a member of the European Crohn's and Colitis Organisation (ECCO) and has been an invited speaker at the ECCO Congress on multiple occasions.

Lauren Swinnen is a Clinical Project Manager and Regulatory & Safety Specialist at Archer Research, where she manages European device studies across different therapeutic areas from start-up through close-out. She holds a PhD in Biomedical Sciences from KU Leuven, where her research focused on a wearable device for long-term epileptic seizure monitoring. Lauren combines hands-on clinical operations experience with regulatory and safety expertise under EU MDR 2017/745, ISO 14155, and GCP. 

Dr Bossuyt studied medicine at the Catholic University of Leuven, Belgium, and graduated magna cum laude in 2004. He pursued his GI fellowship in several hospitals in Belgium and at UZ Leuven. After completing his GI fellowship in 2009, he took up a fellowship in advanced endoscopy at the Academic Medical Centre, Amsterdam. Between 2010 and 2015 he was a consulting staff member at the University Hospitals of Leuven. He obtained a PhD entitled “Value of endoscopic scoring and imaging for the prognosis and follow up of IBD” at the University of Leuven in 2021. His research focuses on clinical and strategic trials in IBD and the definitions of endoscopic and imaging targets in IBD. His clinical works focuses on e-health tools in IBD and quality improvement projects.

He is currently international principal investigator of 3 clinical trials in IBD and endoscopy. He is an editorial board member of the Journal of Crohn’s and Colitis, past-president of the Belgian IBD Research and Development Group, past-board member of ECCO’s Clinical Research Committee, ClinCom and past-board member of the Belgian society of gastrointestinal endoscopy, BSGIE. He won the Belgian IBD research price in 2011, 2021 and 2025, the ESGE Innovation of the year award in 2018 and the ECCO IIS award in 2025. He published over 150 peer-reviewed articles in the NEJM, Lancet, JAMA, Gastroenterology, Gut, Lancet Gastroenterology and Hepatology, JCC among others (H-index 48).